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International Collaborative Group on HNPCC（ICG-HNPCC）
を Lynchらとともに構成，国際協力体制をとった。
ICG-HNPCCは年１回の会合を重ね，１９９０年には本症の




























１．At least three relatives with histologically verified colorectal
cancers ; one of the relatives should be a first degree
relative to the other two.
Familial adenomatous polyposis should be excluded.
２．At least two succesive generations should be affected.
３．In one of the relatives colorectal cancer should be diagnosed












































































































































A : A case with 3 or more colorectal cancers within the first de-
gree relatives.
B : A case with 2 or more colorectal cancers within the first de-
gree relatives and with any of the followings :
a) Age at onset of colorectal cancer(s) is younger than 50 years
old.
b) Right colon involvement.
c) Synchronous or metachronous multiple colorectal cancers.
d) Association with extracolorectal malignancy.
(Familial polyposis coli should be excluded)














症 候 群 名 良 性 腫 瘍 悪 性 腫 瘍 非腫瘍性病変
遺伝
形式
遺 伝 子 単離
年
頻度１／×
座 位 命 名
Ａ 遺伝性腫瘍症候群
１ ポリポーシス症候群
１．１ 家族性腺腫性ポリポーシス（familial adenomatous polyposis : FAP）
１．１．１ 単純型 大腸腺腫 大腸癌 CHRPE＊ AD ５q２１ APC １９９１ １，７００
１．１．２ Gardner症候群 大腸腺腫 デスモイド 骨腫
１．１．３ Turcot症候群（優性型） 大腸腺腫 大腸癌 脳腫瘍
１．１．４ Turcot症候群（劣性型） AR ７q２２ hMPS 2
１．２ Peutz-Jeghers症候群 胃腸過誤腫 多臓器癌 口唇色素斑 AD １９p LKB 1
１．３ 若年性ポリポーシス
（juvenile polyposis : JP）
胃腸過誤腫 奇形 AD １０q２２
３q２４．１
PTEN １９９７


















３ 家族性膵癌 膵癌 AD ？
４ 家族性乳癌（familial breast cancer : BRCA）
４．１ 家族性乳癌／卵巣癌 乳癌 卵巣癌 AD １７q２１ BRCA 1 １９９４
４．２ 家族性乳癌（早発型） 乳癌 AD １３q１２／１３ BRCA 2 １９９４
４．３ 家族性乳癌（晩発型） 乳癌 男性乳癌 AD ６q ESR
４．４ 家族性乳癌 乳癌 男性乳癌 AD BRCA 3?
５ 多発性内分泌腫瘍症（multiple endocrine neoplasia : MEN）
５．１ MEN１(Werner症候群） 島細胞腫 副甲状腺 下垂体 副腎腺腫 AD １１q１２‐１３
５．２ MEN２A(Sipple症候群） 褐色細胞腫 甲状腺髄様癌 AD １０q１１．２ RET １９９３ ２００，０００





Marfan症候群 AD １０q１１．２ RET １９９３
６ 家族性前立腺癌 前立腺癌 AD １０q２５ MXI 1 １９９５
７ 母斑性基底細胞癌症候群 NBCCS＊（Gorlin症候群） 基底細胞癌 AD ９p２２．３ PTCH １９９６
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症 候 群 名 良 性 腫 瘍 悪 性 腫 瘍 非腫瘍性病変
遺伝
形式
遺 伝 子 単離
年
頻度１／×
座 位 命 名
９ 家族性黒色腫
９．１ 家族性異型性ほくろ黒色腫症候群 FDN＊ 異型性ほくろ 黒色腫 AD ９p１３‐２２ MLM １９９４
９．２ 家族性黒色腫 黒色腫
１０ 母斑症（phacomatosis）








カフェ・オ・レ斑 AD １７q１１．２ NF 1 １９９０ ３，５００
１０．１．２ NF２型（両側性聴神経腫） 聴神経鞘腫 髄膜腫 AD ２２q１２‐ NF 2 １９９３ ５，０００
１０．２ 結節性硬化症










１０．３ von Hippel-Lindau病（VHL） 網膜小脳血管
腫褐色細胞腫
腎細胞癌 AD ３p２５‐２６ VHL １９９３












（juvanile polyposis syndrome : JPS）









AD １１p１３ WT 1 １９９０
１２．１．２ Denys-Drash症候群 Wilms腫瘍 男性擬半陰陽
腎症









AD １１p１５ WT 2
１２．２ 網膜芽細胞腫
（retinoblastoma : RB）
網膜芽細胞腫 骨肉腫 １３q１４．２ RB １９８６
１２．３ 神経芽細胞腫 副腎神経芽細胞 AD １p３６
１３ Li-Fraumenl 症候群 骨肉腫 乳癌 褐色細胞腫
胃癌
AD １７p１３ TP 53 １９９０
Ｂ 高発癌性遺伝病
１ 免疫欠損症

























症 候 群 名 良 性 腫 瘍 悪 性 腫 瘍 非腫瘍性病変
遺伝
形式
遺 伝 子 単離
年
頻度１／×




皮膚癌 色素斑 AR ９q３４．１ XPA １９９０ ２５０，０００
２．２ 末梢血管拡張性運動失調症







AR １１q２３ AT １９９５















３．１ Werner症候群 肉腫 甲状腺癌 早老症候群 AR ９q３４．１ WRN
＊表中略語説明
CHRPE : congenital hypertrophy of the retinal pigment epithelium 先天性網膜色素細胞過形成
FMTC : familial medullary thyroid cancer
NBCCS : nevoid basal cell cancer syndrome
FDN : familial dysplastic nevus
BBR : Banayan-Riley-Rubalcava
WAGR : Wilms' tumor aniridia, genitourinary malformation, mental retardation
AD : autosomal dominant
XR : X linked recessive





同 意 語 割 合
環境要因 遺伝要因
oncodeme１ 平均的 平均的 偶発（random）癌 unavoidable cancer ２０％
oncodeme２ 著明に増加 平均的 環境性癌 職業癌，ウイルス性癌 ７５％
oncodeme３ やや増加 やや増加 多因子性癌 家族性腫瘍
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Hereditary tumors
Kazufumi Kunitomo
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SUMMARY
Heredity of malignant diseases has been an inexplicable issue for a long time. Because
there was less precise description or undeveloped genetic science, most of those cases were
explained as a coincidental accumulation of cancer. Recent advantage of microbiology re-
vealed many of responsible genes for diseases including some malignancies. Familial
adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC) are
well-investigated autosomal dominant diseases among them. In 1992, HNPCC patients in
Japan were firstly screened by newly developed Japanese Clinical Criteria. During the study,
777 families were collected from 32470 colorectal cancer patients in 60 institutions in Japan.
They showed features as an early age of onset, right colon involvement, and association of
many other malignancies. Currently, hereditary tumor syndromes are classified in two
categories ; A) Hereditary tumor syndrome including FAP, HNPCC, multiple endocline
neoplasia (MEN) I and II etc, and B) Hereditary condition susceptible for cancer including
xeroderma pigmentosusm, ataxia pigmentosum etc. Present investigations suggest an inci-
dence of hereditary cancers as high as 5-10% of all cancers. It is not so high but study of
these conditions may give a great advantage upon a carcinogenesis and treatment of all
other malignancies. However, we have to pay a careful attention to the ethical, legal, and
social issue that might be developed by the study.
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